XTLB (XTL Biopharmaceuticals) FCF Margin %: 0.00% (As of Jun. 2025)

What is XTL Biopharmaceuticals FCF Margin %?

XTL Biopharmaceuticals XTLB -8.01% 24 FCF Margin % is 0.00% as of Jun. 2025. GuruFocus rates XTLB with a GF Score™ of 24/100. The stock has 2 warning signs investors should review. Among 960 Biotechnology companies, XTL Biopharmaceuticals ranks worse than 58.96% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. XTL Biopharmaceuticals's Free Cash Flow for the six months ended in Jun. 2025 was $0.00 Mil. XTL Biopharmaceuticals's Revenue for the six months ended in Jun. 2025 was $0.52 Mil. Therefore, XTL Biopharmaceuticals's FCF Margin % for the quarter that ended in Jun. 2025 was 0.00%.

As of today, XTL Biopharmaceuticals's current FCF Yield % is -28.80%.

The historical rank and industry rank for XTL Biopharmaceuticals's FCF Margin % or its related term are showing as below:

XTLB' s FCF Margin % Range Over the Past 10 Years
Min: -370.61 Med: -370.61 Max: -172.73
Current: -172.73

During the past 13 years, the highest FCF Margin % of XTL Biopharmaceuticals was -172.73%. The lowest was -370.61%. And the median was -370.61%.

XTLB's FCF Margin % is ranked worse than
58.96% of 960 companies
in the Biotechnology industry
Industry Median: -85.21 vs XTLB: -172.73

XTL Biopharmaceuticals FCF Margin % Related Terms

XTL Biopharmaceuticals FCF Margin % Historical Data

* Premium members only.

The historical data trend for XTL Biopharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XTL Biopharmaceuticals FCF Margin % Chart

XTL Biopharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

0.00

-370.73

XTL Biopharmaceuticals Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25
FCF Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

XTLB vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, XTL Biopharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

XTL Biopharmaceuticals FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, XTL Biopharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where XTL Biopharmaceuticals's FCF Margin % falls into.

Save Embed

24GF Score

XTL Biopharmaceuticals Ltd XTLB

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

XTL Biopharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

XTL Biopharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-1.672	/	0.451
	=	-370.73 %

XTL Biopharmaceuticals's FCF Margin for the quarter that ended in Jun. 2025 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2025 )	/	Revenue (Q: Jun. 2025 )
	=	0	/	0.517
	=	0.00 %

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of 0.00% mean?

XTL Biopharmaceuticals (XTLB) has a FCF Margin % of 0.00% as of Jun. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on XTL Biopharmaceuticals and its competitors. According to the industry distribution chart, XTL Biopharmaceuticals ranks #566 out of 960 companies in the Biotechnology industry, placing it in the top 59%.

Is XTL Biopharmaceuticals' FCF Margin % too high?

XTL Biopharmaceuticals' current FCF Margin % is 0.00%. Based on the distribution chart, XTL Biopharmaceuticals ranks #566 out of 960 companies in the Biotechnology industry, which is below the industry midpoint. Overall, XTL Biopharmaceuticals has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.

How does XTL Biopharmaceuticals' FCF Margin % compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, XTL Biopharmaceuticals ranks #566 out of 960 companies for FCF Margin %. This places XTL Biopharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Biotechnology company?

A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on XTL Biopharmaceuticals and its competitors. XTL Biopharmaceuticals's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is XTL Biopharmaceuticals stock overvalued right now?

XTL Biopharmaceuticals (XTLB) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. XTL Biopharmaceuticals' overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For XTL Biopharmaceuticals (XTLB), the current FCF Margin % is 0.00% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

XTL Biopharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies XTAE:PPBT XTAE:CANF XTAE:EVGN XTAE:HDST-M XTAE:BOLT XTAE:BLRX XTAE:CBI VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270 RPRX BNTX INSM

Other Exchanges XTLB:Israel HHB0:Germany

Address 26 Ben-Gurion Street, Ramat Gan, ISR, 5112001

Website https://www.xtlbio.com

XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.

24GF Score

Get the complete analysis for XTLB

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.57

Price

View XTLB Analysis

See FCF Margin % data for all stocks →